2019
DOI: 10.2147/copd.s207363
|View full text |Cite
|
Sign up to set email alerts
|

<p>Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?</p>

Abstract: Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD) and is associated with increased morbidity and mortality. Reference standard method to diagnose PH is right heart catheterization. Several non-invasive imaging techniques have been employed in the detection of PH. Among them, computed tomography (CT) is the most commonly used for phenotyping and detecting complications of COPD. Several CT findings have also been described in patients with severe PH. Nevertheles… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 136 publications
0
11
0
1
Order By: Relevance
“…Although low-dose chest CT might not be the best modality for measuring cardiac indices, compared to other techniques, it is safer, rapid, and readily available while also having acceptable performance (8,19,34). For instance, right heart catheterization, which is the golden standard test for the diagnosis of PH (35), is costly and aggressive, contributing to serious adverse events such as pneumothorax, arrhythmias and even death in unstable patients (36,37). Also, despite the fact that chest X-ray is widely utilized for the measurement of CTR, it is difficult and suboptimal to perform plain chest radiography for most hospitalized patients with COVID-19 since it requires upright position and unlike chest CT, it does not provide further diagnostic and prognostic value in the setting of COVID-19.…”
Section: Discussionmentioning
confidence: 99%
“…Although low-dose chest CT might not be the best modality for measuring cardiac indices, compared to other techniques, it is safer, rapid, and readily available while also having acceptable performance (8,19,34). For instance, right heart catheterization, which is the golden standard test for the diagnosis of PH (35), is costly and aggressive, contributing to serious adverse events such as pneumothorax, arrhythmias and even death in unstable patients (36,37). Also, despite the fact that chest X-ray is widely utilized for the measurement of CTR, it is difficult and suboptimal to perform plain chest radiography for most hospitalized patients with COVID-19 since it requires upright position and unlike chest CT, it does not provide further diagnostic and prognostic value in the setting of COVID-19.…”
Section: Discussionmentioning
confidence: 99%
“…For example, COPD patients with similar airflow limitation may have substantial near homogeneously-distributed emphysema without airway disease, moderate upper-dominant heterogeneously-distributed emphysema with moderate airway disease, or little emphysema with severe airway disease ( Schroeder et al, 2013 ; Lynch et al, 2015 ). Furthermore, morphological alteration of vessels is also a pathological feature, and pulmonary hypertension is a common comorbidity in patients with COPD ( Matsuoka et al, 2010 ; Coste et al, 2019 ). A combination of these airway, lung parenchyma, and vessel lesions underlies the structural heterogeneity, which not only influences lung function but can be a driving factor for the disease progression in patients with COPD ( Mondoñedo et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Pulmonary vascular changes are one of the important mechanisms involved in the exacerbation of patients with acute exacerbations [ 31 ]. Clinically, patients with COPD can be divided into mild, moderate and severe three levels according to their clinical manifestations, arterial blood gas analysis and other indicators to guide clinical management strategies.…”
Section: Discussionmentioning
confidence: 99%